CLEAN : Danish developers of only licensed monkeypox vaccine ready to meet global demand

The video discusses the smallpox vaccine, which uses MVA BN technology and was approved for monkeypox in 2019. It highlights the vaccine's relevance to international health and its manufacturing capacity of 30 million doses annually, ensuring global supply. The vaccine can be used post-exposure or as a prophylactic measure against monkeypox.

What new insight or understanding did you gain from this video?